Beatrice Bowlby

London

Assistant Editor at Biotechniques: the International Journal of Life Science Methods

Featured in: Favicon

biotechniques.com Favicon

biorxiv.org

Articles

Meet the judges | BioTechniques Image Competition 2025

1 week ago | biotechniques.com | Beatrice Bowlby

We are excited to announce our judging panel for the 2025 Image Competition. After our submission window has closed, your images and supporting information will be sent to our judges. They will score each image based on scientific impact, image quality and wow factor, narrowing the pool of images down to the ten highest scorers. Then, we hand over to you; a public vote will follow, allowing you to choose which image is your favorite.
Perfect bloom's chaotic secret: stochastic expression underlying flower growth

1 week ago | biotechniques.com | Beatrice Bowlby

Original story from Cornell University (NY, USA). Random gene expression underlying flower growth has been revealed. Flowers grow stems, leaves and petals in a perfect pattern again and again. A new Cornell University study shows that even in this precise, patterned formation in plants, gene activity inside individual cells is far more chaotic than it appears from the outside.
Building vascularized stem cell-derived islet organoids

1 week ago | biotechniques.com | Beatrice Bowlby

Original story from the Max Delbrück Center for Molecular Medicine (Berlin, Germany). A vascularized organoid model of hormone secreting cells in the pancreas has been developed, with potential to improve diabetes research and cell-based therapies.
Developing and delivering mRNA lipid nanoparticle therapeutics

1 week ago | biotechniques.com | Beatrice Bowlby

Örn Almarsson is the Co-Founder and CEO of a startup biopharma company called Axelyf (Hafnarfjörður, Iceland & MA, USA) that is developing lipid technologies to safely and efficiently deliver mRNA therapeutics. Örn previously worked for companies like Merck (PA, USA) and Moderna (MA, USA), where he and his team developed therapeutic delivery systems for mRNA, before co-founding Axelyf.
How does Alzheimer’s disease affect tissues other than the brain?

1 week ago | biotechniques.com | Beatrice Bowlby

A new study highlights how both neuronal and peripheral tissues become disrupted in Alzheimer’s disease. A team of researchers from Baylor College of Medicine (TX, USA), the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (TX, USA) and other collaborating institutions have investigated how Alzheimer’s disease (AD) affects different tissues within an organism.
An Insight into Computational Protein Design

2 weeks ago | biotechniques.com | Beatrice Bowlby

Jue Wang is a research scientist and one of the scientific leads of the protein design team at Google DeepMind (London, UK). Before joining DeepMind, Jue was a postdoc with David Baker (University of Washington, WA, USA), who was awarded the 2024 Nobel Prize in Chemistry – along with Demis Hassabis and John Jumper (both Google DeepMind, London, UK) for their creation of an AI model that can predict protein structure – for his work in computational protein design.
Uncovering a promising target for malaria therapeutics

2 weeks ago | biotechniques.com | Beatrice Bowlby

A family of parasite proteins could be a promising new malaria drug target. Over 200 million people contract malaria every year; while treatments are available, growing drug resistance remains a serious issue.
From pixels to patients: tools for the integration of spatial omics data

2 weeks ago | biotechniques.com | Beatrice Bowlby

Jovan Tanevski is a group leader at the Institute of Computational Biomedicine at Heidelberg University Hospital (Germany), who focuses on problem-driven development of AI and machine learning approaches to data exploration, hypothesis generation and computational scientific discovery to facilitate translational biomedicine.
The biotech bi-weekly: launching a groundbreaking longevity accelerator, a landmark cell analyzer and prosperous partnerships

2 weeks ago | biotechniques.com | Beatrice Bowlby

Over the last two weeks, several partnerships have formed that have propelled peptide manufacturing, the modernization of a statistical computing environment, the development of novel antibody–drug conjugates and the development of immunotherapies targeting novel, cancer-specific proteins. Plus, funding for longevity research and the announcement of the ELRIG Drug Discovery 2025 keynote speakers.
Now you see me: machine learning model makes spectra clearer

1 month ago | biotechniques.com | Beatrice Bowlby

A machine learning model has been developed that makes optical spectroscopy data easier and quicker to interpret. Researchers from Rice University (TX, USA) have developed a new machine learning algorithm that interprets optical spectra of molecules, materials and disease biomarkers in biological samples, including fluid samples containing SARS-CoV-2 spike protein. The model could be used to improve diagnostics and sample analysis.